Elite Health Systems Inc.
An OTC-listed healthcare infrastructure company with a strong cash balance but facing significant operational deficits and zero reported revenue.
An OTC-listed healthcare infrastructure company with a strong cash balance but facing significant operational deficits and zero reported revenue.
Investors might consider EHSI as a deep-value speculative play due to its fortress balance sheet with $4.0M in cash against negligible liabilities of $143k, creating a wide margin of safety. The company's ability to raise capital ($4.8M in financing cash flow) suggests management can secure funding for a turnaround or pivot without immediate liquidity risk. Additionally, the zero cost of revenue structure implies that any future revenue generation could result in high gross margins once operational hurdles are cleared.
The stock should be avoided by income-focused investors as the company has recorded consecutive annual losses totaling over $4M since 2022 with absolutely zero reported revenue. The heavy reliance on external financing ($4.8M) to cover operating deficits and affiliate losses points to an unsustainable burn rate that threatens long-term solvency if capital markets tighten. Furthermore, the significant deficit in retained earnings ($-4.4M) and negative cash flow from operations indicate a fundamental inability to generate organic value.
Elite Health Systems Inc. (EHSI) is a healthcare infrastructure entity listed on the OTC market with a streamlined balance sheet. The company operates in the specialized health services sector, focusing on asset-light operational models where cost of revenue is currently nil, suggesting a service-based or holding structure. With minimal current liabilities and a significant cash position relative to debt, the firm maintains a conservative financial posture despite recent net losses.
Elite Health Systems Inc. has maintained a robust liquidity position with $4.0M in ending cash, yet it continues to struggle with profitability, recording a net loss of $-2.1M in 2024 compared to -$0.8M in 2023. The company's cash flow from operations was negative ($-1.5M), largely driven by high general and administrative expenses ($1.8M) with no cost of revenue, indicating a disconnect between spending and income generation. While the firm successfully raised $4.8M through financing to offset these outflows, the recurring losses and zero revenue trend over the last five years signal significant operational challenges that require immediate strategic resolution.
The healthcare services industry is currently undergoing rapid consolidation and regulatory scrutiny, requiring robust balance sheets to navigate reimbursement changes. Companies in this sector often face high capital expenditures for technology and compliance, yet EHSI stands out with minimal fixed assets but lacks the revenue scale typical of mature peers. Success in this environment depends on efficient cost management and the ability to monetize specialized services or assets quickly.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Operating Expenses | $1.4M | $765.0K | $1.8M |
| Operating Income | $-1.4M | $-765.0K | $-1.8M |
| G&A | $1.4M | $765.0K | $1.8M |
| Other OpEx | $0 | $0 | $0 |
| Non-Operating Income | $-147.0K | $-51.0K | $-425.0K |
| Interest Expense | $0 | $2.0K | — |
| Pre-Tax Income | $-1.5M | $-816.0K | $-2.2M |
| Income Tax | $39.0K | $0 | $-163.0K |
| Continuing Ops | $-1.6M | $-816.0K | $-2.1M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-1.6M | $-816.0K | $-2.1M |
| Minority Interest | $-235.0K | $0 | $0 |
| Net to Common | $-1.3M | $-816.0K | $-2.1M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $1.6M | $527.0K | $4.2M |
| Cash & Equivalents | $1.5M | $466.0K | $4.0M |
| Accounts Receivable | $0 | $0 | — |
| Other Current Assets | $18.0K | $61.0K | $215.0K |
| Long-Term Assets | $192.0K | $794.0K | $72.0K |
| PP&E (Net) | $20.0K | $85.0K | $72.0K |
| Goodwill | $0 | — | $0 |
| Operating Leases | $20.0K | $85.0K | $72.0K |
| Other LT Assets | $-5.0K | $435.0K | $-72.0K |
| Total Assets | $1.7M | $1.3M | $4.3M |
| Current Liabilities | $280.0K | $607.0K | $94.0K |
| Current Leases | $23.0K | $27.0K | $34.0K |
| Taxes Payable | $171.0K | $166.0K | — |
| Other Current Liab | $86.0K | $414.0K | $60.0K |
| Long-Term Liabilities | $11.0K | $69.0K | $49.0K |
| LT Operating Leases | $0 | $58.0K | $38.0K |
| Other LT Liab | $11.0K | $11.0K | $11.0K |
| Total Liabilities | $291.0K | $676.0K | $143.0K |
| Shareholders' Equity | $1.5M | $645.0K | $4.2M |
| Retained Earnings | $-1.7M | $-2.4M | $-4.4M |
| Total L&E | $1.7M | $1.3M | $4.3M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-1.6M | $-816.0K | $-2.1M |
| Non-Cash Adjustments | $532.0K | $-86.0K | $517.0K |
| Working Capital Changes | $-373.0K | $11.0K | $23.0K |
| Cash from Operations | $-1.4M | $-891.0K | $-1.5M |
| Cash from Investing | $772.0K | $-180.0K | $263.0K |
| Cash from Financing | $0 | $0 | $4.8M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-641.0K | $-1.1M | $3.6M |
| Beginning Cash | $2.2M | $1.5M | $466.0K |
| Ending Cash | $1.5M | $466.0K | $4.0M |
1) Health Infrastructure Holding: Maintains a substantial cash reserve ($4.0M) and current assets ($4.2M) with no cost of revenue, indicating a holding or service-only business model. 2) Operating Services: Generates minimal operating expenses ($1.8M G&A) without corresponding gross profit, suggesting unprofitable service delivery or early-stage development. 3) Equity Investments: Reports losses from affiliates (-$434k), implying an investment arm or joint venture strategy that is currently underperforming.
1) Persistent Operating Deficits: The company posted a $-2.1M net loss in 2024 and zero revenue, raising questions about the viability of its core business model. 2) Affiliate Loss Exposure: Significant losses from equity affiliates (-$434k) indicate that investments are draining cash without generating sufficient returns to offset operational costs. 3) Revenue Generation Failure: The total revenue is listed as zero, suggesting the company has not yet monetized its assets or services, which is a critical long-term risk. 4) Dilution History: Common share issuances ($92k value) and reliance on financing cash flow suggest ongoing dilution to fund operations in the absence of organic earnings.
1) Fortress Liquidity: The company holds $4.0M in cash and equivalents against only $143k in total liabilities, providing a massive safety margin for operational pivots. 2) Asset Light Structure: With zero cost of revenue and minimal fixed assets ($72k net fixed assets), the business operates with extremely low overhead exposure to market downturns. 3) Financing Capacity: Recent cash flow from financing ($4.8M) demonstrates strong access to capital markets, allowing for aggressive expansion or debt repayment without immediate distress.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.